Concepts (85)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Physical Examination | 2 | 2019 | 299 | 1.210 |
Why?
|
| Atrial Pressure | 1 | 2023 | 6 | 0.910 |
Why?
|
| Strongyloides stercoralis | 1 | 2022 | 22 | 0.880 |
Why?
|
| Strongyloidiasis | 1 | 2022 | 24 | 0.870 |
Why?
|
| Accidental Falls | 1 | 2024 | 142 | 0.850 |
Why?
|
| Patient Positioning | 1 | 2023 | 195 | 0.780 |
Why?
|
| Klebsiella Infections | 1 | 2021 | 64 | 0.770 |
Why?
|
| Thrombophlebitis | 1 | 2020 | 31 | 0.770 |
Why?
|
| Urinary Retention | 1 | 2020 | 21 | 0.760 |
Why?
|
| Cyanosis | 1 | 2020 | 40 | 0.760 |
Why?
|
| Bacteriological Techniques | 1 | 2021 | 121 | 0.750 |
Why?
|
| Webcasts as Topic | 1 | 2020 | 9 | 0.750 |
Why?
|
| Thinking | 1 | 2020 | 33 | 0.740 |
Why?
|
| Narration | 1 | 2020 | 42 | 0.740 |
Why?
|
| Point-of-Care Testing | 1 | 2019 | 24 | 0.680 |
Why?
|
| Learning | 2 | 2020 | 403 | 0.680 |
Why?
|
| Low Back Pain | 1 | 2019 | 83 | 0.650 |
Why?
|
| Muscular Diseases | 1 | 2018 | 161 | 0.610 |
Why?
|
| Capillary Fragility | 1 | 2017 | 1 | 0.600 |
Why?
|
| Hypoxia | 1 | 2019 | 443 | 0.580 |
Why?
|
| Bacteremia | 1 | 2022 | 689 | 0.570 |
Why?
|
| Pneumonia | 1 | 2022 | 751 | 0.560 |
Why?
|
| Osteomyelitis | 1 | 2019 | 236 | 0.560 |
Why?
|
| Oxygen | 1 | 2019 | 754 | 0.520 |
Why?
|
| Bile Ducts, Intrahepatic | 1 | 2017 | 334 | 0.510 |
Why?
|
| Zika Virus Infection | 1 | 2017 | 166 | 0.500 |
Why?
|
| Anterior Wall Myocardial Infarction | 1 | 2012 | 13 | 0.420 |
Why?
|
| Bile Duct Neoplasms | 1 | 2017 | 493 | 0.420 |
Why?
|
| Cholangiocarcinoma | 1 | 2017 | 493 | 0.410 |
Why?
|
| Coronary Thrombosis | 1 | 2012 | 44 | 0.410 |
Why?
|
| Clinical Competence | 2 | 2019 | 1270 | 0.400 |
Why?
|
| Internship and Residency | 5 | 2021 | 1375 | 0.390 |
Why?
|
| Drug-Eluting Stents | 1 | 2012 | 131 | 0.380 |
Why?
|
| Thrombosis | 1 | 2017 | 781 | 0.370 |
Why?
|
| Hypertension | 1 | 2019 | 1503 | 0.360 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2012 | 314 | 0.360 |
Why?
|
| Leukemia, Promyelocytic, Acute | 1 | 2012 | 430 | 0.320 |
Why?
|
| Education, Medical | 2 | 2022 | 331 | 0.300 |
Why?
|
| Internal Medicine | 2 | 2016 | 124 | 0.260 |
Why?
|
| Students, Medical | 2 | 2020 | 399 | 0.250 |
Why?
|
| Teaching | 2 | 2016 | 243 | 0.230 |
Why?
|
| Leukostasis | 1 | 2022 | 4 | 0.220 |
Why?
|
| Hospitalists | 1 | 2022 | 57 | 0.200 |
Why?
|
| Teaching Rounds | 1 | 2021 | 33 | 0.200 |
Why?
|
| Humans | 18 | 2024 | 261506 | 0.190 |
Why?
|
| Klebsiella pneumoniae | 1 | 2021 | 98 | 0.190 |
Why?
|
| Aspartate Aminotransferases | 1 | 2018 | 153 | 0.160 |
Why?
|
| Lumbar Vertebrae | 1 | 2019 | 245 | 0.160 |
Why?
|
| Communicable Diseases, Imported | 1 | 2017 | 5 | 0.150 |
Why?
|
| Blood Pressure Determination | 1 | 2017 | 109 | 0.140 |
Why?
|
| Dyspnea | 1 | 2019 | 416 | 0.140 |
Why?
|
| Arteries | 1 | 2017 | 274 | 0.130 |
Why?
|
| Male | 6 | 2024 | 123000 | 0.130 |
Why?
|
| Liver | 1 | 2022 | 2961 | 0.110 |
Why?
|
| Primary Health Care | 1 | 2018 | 787 | 0.110 |
Why?
|
| Diagnosis, Differential | 1 | 2021 | 4744 | 0.100 |
Why?
|
| Bone Marrow Examination | 1 | 2012 | 153 | 0.100 |
Why?
|
| Aged | 3 | 2020 | 70117 | 0.090 |
Why?
|
| Coronary Angiography | 1 | 2012 | 598 | 0.080 |
Why?
|
| Prosthesis Design | 1 | 2012 | 749 | 0.080 |
Why?
|
| Reproducibility of Results | 1 | 2019 | 6009 | 0.080 |
Why?
|
| Anti-Bacterial Agents | 1 | 2021 | 2992 | 0.080 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2012 | 444 | 0.080 |
Why?
|
| Time Factors | 1 | 2020 | 12926 | 0.070 |
Why?
|
| Drug Therapy, Combination | 1 | 2012 | 2315 | 0.070 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2021 | 7551 | 0.060 |
Why?
|
| Aged, 80 and over | 1 | 2024 | 29902 | 0.060 |
Why?
|
| Biopsy | 1 | 2012 | 3443 | 0.060 |
Why?
|
| Recurrence | 1 | 2012 | 4758 | 0.060 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2022 | 6915 | 0.050 |
Why?
|
| Leukocytosis | 1 | 2022 | 112 | 0.050 |
Why?
|
| Leukapheresis | 1 | 2022 | 152 | 0.050 |
Why?
|
| Adult | 2 | 2019 | 77950 | 0.050 |
Why?
|
| Surveys and Questionnaires | 3 | 2021 | 5687 | 0.050 |
Why?
|
| Hydroxyurea | 1 | 2022 | 204 | 0.050 |
Why?
|
| Middle Aged | 2 | 2021 | 86204 | 0.050 |
Why?
|
| Schools, Medical | 1 | 2020 | 132 | 0.040 |
Why?
|
| Animals | 1 | 2022 | 59536 | 0.040 |
Why?
|
| Female | 2 | 2019 | 141928 | 0.040 |
Why?
|
| Chronic Disease | 1 | 2022 | 1819 | 0.040 |
Why?
|
| Massachusetts | 1 | 2016 | 106 | 0.030 |
Why?
|
| Evaluation Studies as Topic | 1 | 2016 | 418 | 0.030 |
Why?
|
| Curriculum | 1 | 2020 | 860 | 0.030 |
Why?
|
| Educational Measurement | 1 | 2015 | 362 | 0.030 |
Why?
|
| Pandemics | 1 | 2021 | 1559 | 0.030 |
Why?
|